Brorson K - Search Results

1

Mycoplasma Clearance and Risk Analysis in a Model Bioprocess.

Wang J, Johnson S, Brown M, Lute S, Agarabi C, Dabrazhynetskaya A, Chizhikov V, Brorson K. Wang J, et al. Among authors: brorson k. PDA J Pharm Sci Technol. 2017 Mar-Apr;71(2):99-114. doi: 10.5731/pdajpst.2016.007054. Epub 2017 Jan 15. PDA J Pharm Sci Technol. 2017. PMID: 28089962

2

Analysis of viral clearance unit operations for monoclonal antibodies.

Miesegaes G, Lute S, Brorson K. Miesegaes G, et al. Among authors: brorson k. Biotechnol Bioeng. 2010 Jun 1;106(2):238-46. doi: 10.1002/bit.22662. Biotechnol Bioeng. 2010. PMID: 20073086

3

A survey of quality attributes of virus spike preparations used in clearance studies.

Miesegaes G, Lute S, Dement-Brown J, Kaushal S, Strauss D, Chen D, Brorson K. Miesegaes G, et al. Among authors: brorson k. PDA J Pharm Sci Technol. 2012 Sep-Oct;66(5):420-33. doi: 10.5731/pdajpst.2012.00879. PDA J Pharm Sci Technol. 2012. PMID: 23035026

4

Bioprocess: Robustness with Respect to Mycoplasma Species.

Faison T, Wang J, Johnson S, Brown M, Chiang MJ, Dolan S, Breuning C, Velugula-Yellela SR, Lute S, Fratz-Berilla EJ, Brorson K. Faison T, et al. Among authors: brorson k. PDA J Pharm Sci Technol. 2020 Mar-Apr;74(2):201-212. doi: 10.5731/pdajpst.2018.009613. Epub 2019 Sep 13. PDA J Pharm Sci Technol. 2020. PMID: 31519782

5

Mycoplasma testing of cell substrates and biologics: Review of alternative non-microbiological techniques.

Volokhov DV, Graham LJ, Brorson KA, Chizhikov VE. Volokhov DV, et al. Mol Cell Probes. 2011 Apr-Jun;25(2-3):69-77. doi: 10.1016/j.mcp.2011.01.002. Epub 2011 Jan 11. Mol Cell Probes. 2011. PMID: 21232597 Review.

6

Bacteriophage and impurity carryover and total organic carbon release during extended protein A chromatography.

Lute S, Brorson K. Lute S, et al. Among authors: brorson k. J Chromatogr A. 2009 May 1;1216(18):3774-83. doi: 10.1016/j.chroma.2009.02.050. Epub 2009 Feb 21. J Chromatogr A. 2009. PMID: 19285678

7

Multiplex RT Q-PCR assay for simultaneous quantification of three viruses used for validation of virus clearance by biopharmaceutical production.

Lute S, Wang H, Sanchez D, Barletta J, Chen Q, Brorson K. Lute S, et al. Among authors: brorson k. Biologicals. 2009 Oct;37(5):331-7. doi: 10.1016/j.biologicals.2009.07.002. Epub 2009 Aug 15. Biologicals. 2009. PMID: 19683941

8

Development of a modular virus clearance package for anion exchange chromatography operated in weak partitioning mode.

Iskra T, Sacramo A, Gallo C, Godavarti R, Chen S, Lute S, Brorson K. Iskra T, et al. Among authors: brorson k. Biotechnol Prog. 2015 May-Jun;31(3):750-7. doi: 10.1002/btpr.2080. Epub 2015 Apr 15. Biotechnol Prog. 2015. PMID: 25826186

9

Comparison of purification strategies for antibodies used in a broad spectrum host cell protein immunoassay.

Baldus PA, Brown M, Wright RS, Campbell JA, Lute S, Chavez B, Brorson K, Mozier N. Baldus PA, et al. Among authors: brorson k. Biotechnol Bioeng. 2018 Feb;115(2):413-422. doi: 10.1002/bit.26482. Epub 2017 Nov 22. Biotechnol Bioeng. 2018. PMID: 29064563

10

The Current Scientific and Regulatory Landscape in Advancing Integrated Continuous Biopharmaceutical Manufacturing.

Fisher AC, Kamga MH, Agarabi C, Brorson K, Lee SL, Yoon S. Fisher AC, et al. Among authors: brorson k. Trends Biotechnol. 2019 Mar;37(3):253-267. doi: 10.1016/j.tibtech.2018.08.008. Epub 2018 Sep 18. Trends Biotechnol. 2019. PMID: 30241924 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

129 results

Search Page

Filters